| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2018 | Hayden Donald J Jr | Director | Sale+OE | 15,000 | $55.01 | $825,149.00 | -100% | |
| May 21, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $47.05 | $470,539.83 | -1.6% | |
| May 15, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 7,500 | $50.10 | $375,720.65 | -1.7% | |
| May 15, 2018 | Hayden Donald J Jr | Director | Sale+OE | 15,000 | $50.05 | $750,796.94 | -100% | |
| May 9, 2018 | Hayden Donald J Jr | Director | Sale+OE | 15,000 | $45.00 | $675,000.00 | -100% | |
| May 9, 2018 | Christmas Patrick J. | SVP, General Counsel | Sale+OE | 15,000 | $43.33 | $650,000.00 | -55.0% | |
| Apr 20, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 10,000 | $39.52 | $395,205.00 | -2.2% | |
| Apr 16, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 5,000 | $37.56 | $187,797.01 | -1.6% | |
| Apr 11, 2018 | Christmas Patrick J. | SVP, General Counsel | Sale+OE | 10,000 | $39.00 | $390,000.00 | -89.8% | |
| Apr 9, 2018 | Christmas Patrick J. | SVP, General Counsel | Sale+OE | 10,000 | $34.00 | $340,000.00 | -89.8% |